1. Home
  2. ELWS vs CDT Comparison

ELWS vs CDT Comparison

Compare ELWS & CDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELWS
  • CDT
  • Stock Information
  • Founded
  • ELWS 2018
  • CDT 2019
  • Country
  • ELWS Japan
  • CDT United States
  • Employees
  • ELWS N/A
  • CDT N/A
  • Industry
  • ELWS
  • CDT Biotechnology: Pharmaceutical Preparations
  • Sector
  • ELWS
  • CDT Health Care
  • Exchange
  • ELWS Nasdaq
  • CDT Nasdaq
  • Market Cap
  • ELWS 6.0M
  • CDT 5.3M
  • IPO Year
  • ELWS 2023
  • CDT N/A
  • Fundamental
  • Price
  • ELWS $1.85
  • CDT $0.40
  • Analyst Decision
  • ELWS
  • CDT
  • Analyst Count
  • ELWS 0
  • CDT 0
  • Target Price
  • ELWS N/A
  • CDT N/A
  • AVG Volume (30 Days)
  • ELWS 25.1K
  • CDT 6.7M
  • Earning Date
  • ELWS 06-03-2025
  • CDT 05-13-2025
  • Dividend Yield
  • ELWS N/A
  • CDT N/A
  • EPS Growth
  • ELWS N/A
  • CDT N/A
  • EPS
  • ELWS N/A
  • CDT N/A
  • Revenue
  • ELWS $2,292,406.00
  • CDT N/A
  • Revenue This Year
  • ELWS N/A
  • CDT N/A
  • Revenue Next Year
  • ELWS N/A
  • CDT N/A
  • P/E Ratio
  • ELWS N/A
  • CDT N/A
  • Revenue Growth
  • ELWS 404.13
  • CDT N/A
  • 52 Week Low
  • ELWS $1.04
  • CDT $0.51
  • 52 Week High
  • ELWS $8.68
  • CDT $350.00
  • Technical
  • Relative Strength Index (RSI)
  • ELWS 42.03
  • CDT 31.05
  • Support Level
  • ELWS $1.81
  • CDT $0.37
  • Resistance Level
  • ELWS $2.06
  • CDT $0.57
  • Average True Range (ATR)
  • ELWS 0.18
  • CDT 0.05
  • MACD
  • ELWS 0.00
  • CDT 0.01
  • Stochastic Oscillator
  • ELWS 10.26
  • CDT 12.30

About ELWS Earlyworks Co. Ltd.

Earlyworks Co Ltd is a blockchain-based technology company. It builds products, delivers services, and develops solutions based on a proprietary grid ledger system to leverage blockchain technology in various business settings, including advertisement tracking, online visitor management, and sales of non-fungible tokens. The company's customers represent a diverse range of industries, such as information technology, shipping, real estate, entertainment, cosmetics, and chemical products.

About CDT Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

Share on Social Networks: